The $600mn of funding 23andMe raised in its 2021 merger with ... Drugmaker Mallinckrodt, cleansed of its opioid-related legacy, recently merged with rival Endo in a $6.7bn deal.

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...

Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim view Thursday. Shares of Endo fell more ...

Albertsons terminated the merger immediately after courts blocked it and sued Kroger, alleging a breach of contract that led to the deal falling apart. Sign up here. The formal termination ended a ...

Endo International is the latest drugmaker ... opioid settlement and corporate restructuring terms – as well as Mallinckrodt, which emerged from chapter 11 after agreeing a $1.6 billion ...

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given ...

Jordyn joined Investopedia in February 2025. She was previously a freelance writer covering lifestyle, entertainment, politics in the Midwest, and more. Getty Images A new survey dove into the ...

Her expertise is in personal finance and investing, and real estate. A stock-for-stock merger occurs when shares of one company are traded for another during an acquisition. Shareholders can trade ...